Acrivon Therapeutics
ACRV
ACRV
55 hedge funds and large institutions have $136M invested in Acrivon Therapeutics in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.28% more ownership
Funds ownership: 68.7% → 75.99% (+7.3%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
55
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$28.4M | |
| 2 | +$19M | |
| 3 | +$5.31M | |
| 4 |
SCV
Sands Capital Ventures
Arlington,
Virginia
|
+$3.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$3.54M |
Top Sellers
| 1 | -$683K | |
| 2 | -$387K | |
| 3 | -$175K | |
| 4 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
-$107K |
| 5 |
PCM
Prelude Capital Management
New York
|
-$93K |